July 2023 Prescription Drug Affordability Board Meeting
- Date and time: July 24th, 2023 2:00 pm
Public Comment
The Board has set aside an opportunity for public comment during the meeting. Public comments must concern an agenda item and are limited to one minute and thirty seconds per comment. If you are interested in registering to make a public comment, please email [email protected] no later than the close of business on Friday, July 21, 2023, and provide:
- Your name
- Your address
- The agenda item your comment will address. PDAB staff will reach out to you directly to confirm your reservation or provide additional detail.
Written Comment
The public may also submit written comments on the Board's pending decisions, or general comments regarding the Board's work, to [email protected]. Please submit any written comments concerning this agenda no later than the close of business on Friday, July 21, 2023.
Agenda and Meeting Materials
- Agenda - PDF - 84.45 KB
- Minutes - PDF - 160.07 KB
- COMAR 14.01.01 General Provisions (14.01.01.01 Definitions, 14.01.01.02 Rules of Construction, 14.01.01.03 Open Meetings, 14.01.01.04 Confidential, Trade-Secret and Proprietary Information, 14.01.01.05 Public Comment Procedures) - PDF - 170.71 KB
- COMAR 14.01.04 Cost Review Study Process (14.01.04.01 Public Reporting of Drug Affordability Issues, 14.01.04.02 Identifying Drugs Eligible for Cost Review, 14.01.04.03 Selecting Drugs for Cost Review, 14.01.04.04 Request for Information for Cost Review, 14.01.04.05 Cost Review Study) - PDF - 195.77 KB
- Staff Presentation on Comments and Regulations - PDF - 159.58 KB
Presentation on Upper Payment Limit Action Plan - PDF - 425.76 KB
Written Comments Received:
Comment Letter: Jane Horvath (Updated on 7/20/2023) - PDF - 222.64 KB